KORU Medical Systems, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M |
| Gross profit | $25.6M | $21.3M | $16.7M | $15.4M | $13.8M |
| Operating income | -$3.0M | -$6.4M | -$10.3M | -$10.8M | -$7.0M |
| Operating expenses | $28.6M | $27.8M | $27.0M | $26.1M | $20.8M |
| Cost of revenue | $15.5M | $12.3M | $11.8M | $12.5M | $9.7M |
| Cash from operations | $462,405 | -$319,718 | -$4.9M | -$5.4M | -$4.3M |
| Capital expenditure | $932,517 | $1.3M | $782,949 | $2.8M | $346,178 |
| Free cash flow | -$470,112 | -$1.6M | -$5.7M | -$8.2M | -$4.7M |
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M | $41.3M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M | $4.8M |
Shares outstanding 45.9M · Free float 81.9%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.